Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytes.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 25060556)

Published in Cardiovasc Drugs Ther on October 01, 2014

Authors

Michael Lever1, Christopher J McEntyre, Peter M George, Sandy Slow, Jane L Elmslie, Helen Lunt, Stephen T Chambers, Amber Parry-Strong, Jeremy D Krebs

Author Affiliations

1: Biochemistry Unit, Canterbury Health Laboratories, P.O. Box 151, Christchurch, 8140, New Zealand, michael.lever@otago.ac.nz.

Articles by these authors

Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med (2009) 7.82

A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet (2011) 5.61

Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int (2010) 3.37

Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int (2011) 3.05

Impact of routine systematic polymerase chain reaction testing on case finding for Legionnaires' disease: a pre-post comparison study. Clin Infect Dis (2013) 2.28

Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA (2012) 2.27

A comparison between two strategies for monitoring hepatic function during antituberculous therapy. Am J Respir Crit Care Med (2011) 2.22

Use of ethanol locks to prevent recurrent central line sepsis. J Infect (2004) 1.69

Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine. Cardiovasc Drugs Ther (2009) 1.49

Peritonsillar infection in Christchurch 2006-2008: epidemiology and microbiology. N Z Med J (2011) 1.46

Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis. Br J Haematol (2007) 1.43

The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. Clin Biochem (2010) 1.43

Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia. J Clin Microbiol (2003) 1.41

Prospective validation of cerebrospinal fluid bilirubin in suspected subarachnoid haemorrhage. Ann Clin Biochem (2007) 1.40

CAPD in sheep following bilateral nephrectomy. Perit Dial Int (2006) 1.40

Cutaneous myiasis due to Dermatobia hominis (the human botfly) in a New Zealand traveller returned from South America. N Z Med J (2009) 1.39

Coenzyme Q10: an independent predictor of mortality in chronic heart failure. J Am Coll Cardiol (2008) 1.35

Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia. Am J Cardiol (2007) 1.31

First national audit of the outcomes of care in young people with diabetes in New Zealand: high prevalence of nephropathy in Maori and Pacific Islanders. N Z Med J (2006) 1.28

The scent of Mycobacterium tuberculosis--part II breath. Tuberculosis (Edinb) (2009) 1.27

Antibiotic resistance in uncomplicated urinary tract infection: problems with interpreting cumulative resistance rates from local community laboratories. N Z Med J (2002) 1.23

Contamination of Qiagen DNA extraction kits with Legionella DNA. J Clin Microbiol (2003) 1.22

Cystatin C--a paradigm of evidence based laboratory medicine. Clin Biochem Rev (2008) 1.17

Recurrent breast abscess caused by Gordonia bronchialis in an immunocompetent patient. J Clin Microbiol (2005) 1.17

Double complex mutations involving F8 and FUNDC2 caused by distinct break-induced replication. Hum Mutat (2007) 1.15

Trimethylaminuria: causes and diagnosis of a socially distressing condition. Clin Biochem Rev (2011) 1.12

Incidence of type 1 diabetes mellitus diagnosed before age 20 years in Canterbury, New Zealand over the last 30 years. J Pediatr Endocrinol Metab (2002) 1.10

Mutant fibrinogen cleared from the endoplasmic reticulum via endoplasmic reticulum-associated protein degradation and autophagy: an explanation for liver disease. Am J Pathol (2006) 1.09

The scent of Mycobacterium tuberculosis. Tuberculosis (Edinb) (2008) 1.08

Detection of factor VIII gene mutations by high-resolution melting analysis. Clin Chem (2007) 1.08

The relative effects of fat versus muscle mass on cystatin C and estimates of renal function in healthy young men. Ann Clin Biochem (2012) 1.06

Investigation into the production of 2-Pentylfuran by Aspergillus fumigatus and other respiratory pathogens in vitro and human breath samples. Med Mycol (2008) 1.06

2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung. BMC Pulm Med (2010) 1.05

Vitamin D receptor genotypes influence the success of calcitriol therapy for recurrent vertebral fracture in osteoporosis. Pharmacogenet Genomics (2005) 1.05

Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa. Atherosclerosis (2007) 1.02

Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-α antagonist therapy. Thorax (2013) 1.00

Plasma lipids and betaine are related in an acute coronary syndrome cohort. PLoS One (2011) 0.97

Homocysteine, glycine betaine, and N,N-dimethylglycine in patients attending a lipid clinic. Metabolism (2005) 0.96

Coenzyme Q10: is there a clinical role and a case for measurement? Clin Biochem Rev (2008) 0.95

Novel fibrinogen gamma375 Arg-->Trp mutation (fibrinogen aguadilla) causes hepatic endoplasmic reticulum storage and hypofibrinogenemia. Hepatology (2002) 0.94

A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment. Hum Mutat (2009) 0.93

Outpatient intravenous treatment for infective endocarditis: safety, effectiveness and one-year outcomes. J Infect (2009) 0.93

Circulating markers of inflammation and their link to indices of adiposity. Obes Facts (2008) 0.93

Impact of prandial status on the comparison of capillary glucose meter and venous plasma glucose measurements in healthy volunteers. Ann Clin Biochem (2012) 0.93

Effects of orange juice and proline betaine on glycine betaine and homocysteine in healthy male subjects. Eur J Nutr (2007) 0.93

Proteome-wide analysis and CXCL4 in systemic sclerosis. N Engl J Med (2014) 0.92

Use of fully denaturing HPLC for UGT1A1 genotyping in Gilbert syndrome. Clin Chem (2005) 0.92

Dietary and supplementary betaine: acute effects on plasma betaine and homocysteine concentrations under standard and postmethionine load conditions in healthy male subjects. Am J Clin Nutr (2008) 0.92

A glucose meter evaluation co-designed with both health professional and consumer input. N Z Med J (2013) 0.90

Trinucleotide repeat variants in the promoter of the thiopurine S-methyltransferase gene of patients exhibiting ultra-high enzyme activity. Pharmacogenet Genomics (2008) 0.90

Short and long-term variation of plasma glycine betaine concentrations in humans. Clin Biochem (2004) 0.90

Betaine and secondary events in an acute coronary syndrome cohort. PLoS One (2012) 0.90

Oily fish reduces plasma triacylglycerols: a primary prevention study in overweight men and women. Nutrition (2006) 0.89

Successful antimicrobial therapy and implant retention for streptococcal infection of prosthetic joints. ANZ J Surg (2004) 0.88

Benefits of knowledge-based interprofessional communication skills training in medical undergraduate education. JRSM Short Rep (2011) 0.88

Treatment satisfaction after commencement of insulin in Type 2 diabetes. Diabetes Res Clin Pract (2004) 0.88

Comparison of blood glucose meters in a New Zealand diabetes centre. Ann Clin Biochem (2009) 0.88

Free and total cefazolin plasma and interstitial fluid concentrations at steady state during continuous infusion. J Antimicrob Chemother (2002) 0.88

Protein binding of cefazolin is saturable in vivo both between and within patients. Br J Clin Pharmacol (2007) 0.87

Improvements in glucose metabolism and insulin sensitivity with a low-carbohydrate diet in obese patients with type 2 diabetes. J Am Coll Nutr (2013) 0.87

Functional rescue of mutant ABCA1 proteins by sodium 4-phenylbutyrate. J Lipid Res (2012) 0.87

Biomarkers of cardiac dysfunction and mortality from community-acquired pneumonia in adults. PLoS One (2013) 0.87

Separation of cationic aracyl derivatives of betaines and related compounds. J Chromatogr A (2005) 0.87

Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure. Kidney Int (2002) 0.87

Measurement of breath acetone concentrations by selected ion flow tube mass spectrometry in type 2 diabetes. J Breath Res (2011) 0.87

Inter- and intra-individual variations in normal urinary glycine betaine excretion. Clin Biochem (2007) 0.87

Understanding the new HbA1c units for the diagnosis of Type 2 diabetes. N Z Med J (2012) 0.86

Medically facilitated discharge of adult diabetic ketoacidosis admissions: precipitants and average length of stay. N Z Med J (2014) 0.86

Comparison of galactomannan detection, PCR-enzyme-linked immunosorbent assay, and real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model and effect of caspofungin acetate. Clin Diagn Lab Immunol (2005) 0.86

Campylobacter fetus-associated epidural abscess and bacteremia. J Clin Microbiol (2009) 0.86

Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non-ischaemic heart failure. Eur J Heart Fail (2008) 0.86

Evaluation of high-resolution melting analysis for screening the LDL receptor gene. Clin Biochem (2008) 0.86

Betaine analogues alter homocysteine metabolism in rats. Int J Biochem Cell Biol (2004) 0.85

The prevalence of low vitamin B12 status in people with type 2 diabetes receiving metformin therapy in New Zealand--a clinical audit. N Z Med J (2014) 0.85

Performance of Xpert MTB/RIF in the diagnosis of tuberculous mediastinal lymphadenopathy by endobronchial ultrasound. Ann Am Thorac Soc (2014) 0.85

Variability of plasma and urine betaine in diabetes mellitus and its relationship to methionine load test responses: an observational study. Cardiovasc Diabetol (2012) 0.84

Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure. Atherosclerosis (2004) 0.84

Biological variation of coenzyme Q10. Clin Chem (2005) 0.83

Plasma and urine betaine and dimethylglycine variation in healthy young male subjects. Clin Biochem (2009) 0.83